Kirkali, Z. And Tuzel, E. 2009. Systemic therapy of kidney cancer: tyrosine kinase inhibitors, antiangiogenesis or IL-2?. FUTURE ONCOLOGY , vol.5, no.6 , 871-888.

Kirkali, Z., & Tuzel, E., (2009). Systemic therapy of kidney cancer: tyrosine kinase inhibitors, antiangiogenesis or IL-2?. FUTURE ONCOLOGY , vol.5, no.6, 871-888.

Kirkali, Ziya, And Emre Tuzel. "Systemic therapy of kidney cancer: tyrosine kinase inhibitors, antiangiogenesis or IL-2?," FUTURE ONCOLOGY , vol.5, no.6, 871-888, 2009

Kirkali, Ziya And Tuzel, Emre. "Systemic therapy of kidney cancer: tyrosine kinase inhibitors, antiangiogenesis or IL-2?." FUTURE ONCOLOGY , vol.5, no.6, pp.871-888, 2009

Kirkali, Z. And Tuzel, E. (2009) . "Systemic therapy of kidney cancer: tyrosine kinase inhibitors, antiangiogenesis or IL-2?." FUTURE ONCOLOGY , vol.5, no.6, pp.871-888.

@article{article, author={Ziya Kirkali And author={Emre Tuzel}, title={Systemic therapy of kidney cancer: tyrosine kinase inhibitors, antiangiogenesis or IL-2?}, journal={FUTURE ONCOLOGY}, year=2009, pages={871-888} }